Manganese-Induced Parkinsonism due to Ephedrone Abuse
- PMID: 21403909
- PMCID: PMC3043321
- DOI: 10.4061/2011/865319
Manganese-Induced Parkinsonism due to Ephedrone Abuse
Abstract
During recent years, a syndrome of hypokinesia, dysarthria, dystonia, and postural impairment, related to intravenous use of a "designer" psychostimulant derived from pseudoephedrine using potassium permanganate as the oxidant, has been observed in drug addicts in several countries in Eastern Europe with some cases also in Western countries. A levodopa unresponsive Parkinsonian syndrome occurs within a few months of abusing the homemade drug mixture containing ephedrone (methcathinone) and manganese. The development of this neurological syndrome has been attributed to toxic effects of manganese, but the role of the psychostimulant ephedrone is unclear. This paper describes the clinical syndrome, results of neuroimaging, and therapeutic attempts.
Figures
References
-
- Couper J. On the effects of black oxide of manganese when inhaled into the lungs. British Annals of Medicine and Pharmacology. 1837;1:41–42.
-
- Schuler P, Oyanguren H, Maturana V, et al. Manganese poisoning; environmental and medical study at a Chilean mine. Industrial Medicine & Surgery. 1957;26(4):167–173. - PubMed
-
- Josephs KA, Ahlskog JE, Klos KJ, et al. Neurologic manifestations in welders with pallidal MRI T1 hyperintensity. Neurology. 2005;64(12):2033–2039. - PubMed
-
- Nagatomo S, Umehara F, Hanada K, et al. Manganese intoxication during total parenteral nutrition: report of two cases and review of the literature. Journal of the Neurological Sciences. 1999;162(1):102–105. - PubMed
LinkOut - more resources
Full Text Sources
